From Diagnosis to Endocrine Management: Utilizing Genomic Profiling to Inform Comprehensive Treatment Planning for Women with Early-Stage Breast Cancer.

Presented by

Chair: Dr. Jonathan Sackier, Speakers: Dr. William Audeh, Dr. Alberto Montero

About this talk

Allow HCP’s within Oncology to;

  • Understand the latest data supporting the utility of Agendia’s assays: MammaPrint®️ and BluePrint®️ for ER+ patients
  • Review and appreciate the real-world impact of MammaPrint and BluePrint.
  • Recommend genomic profiling for pre-and post-operative breast cancer treatment planning